Abstract
Cancer cells using alternative lengthening of telomeres (ALT) require RAD51AP for telomere maintenance.
Major Finding: Cancer cells using alternative lengthening of telomeres (ALT) require RAD51AP for telomere maintenance.
Mechanism: RAD51AP1 mediates homologous recombination (HR) and break-induced telomere DNA synthesis (BITS).
Impact: RAD51AP1 joins a small group of proteins known to affect both HR and BITS in ALT+ cancer cells.
Cancer cells require a mechanism to maintain telomere length. Although most cancers achieve this by reactivating telomerase, there also exists a separate mechanism called alternative lengthening of telomeres (ALT) that involves RAD51-dependent homologous recombination (HR) followed by break-induced telomere DNA synthesis (BITS). In multiple ALT+ cancer cell lines, Barroso-González and colleagues found that the vertebrate-specific RAD51 partner RAD51AP1 localized to telomeres, and depletion of RAD51AP1 led to telomere fragility and shortening similar to that seen in cells lacking a telomere-elongation mechanism. RAD51AP1 mediated both HR and BITS at telomeres in ALT+ cells, and lack of RAD51AP1 disrupted recruitment of the homology-dependent repair (HDR) factors POLD3 and RAD52 to telomeres. Telomeric DNA fragments expelled into the cytosol in RAD51AP1-deficient ALT+ cells were sensed by cyclic GMP–AMP synthase, triggering AMPK–ULK1-dependent autophagy and promoting cellular survival. MMS21-dependent SUMOylation of RAD51AP1 stabilized RAD51AP1, which led to increased levels of RAD51AP1 in ALT+ cancer cells. Further, SUMOylation of RAD51AP1 was critical for ALT and maintenance of telomere length. Collectively, these results demonstrate a previously unknown role for RAD51AP1 in ALT and suggest that investigation of combined inhibition of HDR and autophagy in ALT+ cancers may be warranted.
Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.